Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancer.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Urology

• Publication date

  2013-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.juro.2013.05.054PMID 23727309
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• What Would You Do, Doctor?

  2014cited by this paper
• Cohort Profile: the National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0.

  2013cited by this paper
• The number of cores taken in patients diagnosed with a single microfocus at initial biopsy is a major predictor of insignificant prostate cancer.

  2013cited by this paper
• Outcome following active surveillance of men with screen-detected prostate cancer. Results from the Göteborg randomised population-based prostate cancer screening trial.

  2013cited by this paper
• Gleason score 6 adenocarcinoma: should it be labeled as cancer?

  2012cited by this paper
• Prostate-cancer mortality at 11 years of follow-up.

  2012cited by this paper
• The watchman.

  2012cited by this paper
• Overtreatment of men with low‐risk prostate cancer and significant comorbidity

  2011cited by this paper
• Men's perspectives on selecting their prostate cancer treatment.

  2011cited by this paper
• Comorbidity, treatment and mortality: a population based cohort study of prostate cancer in PCBaSe Sweden.

  2011cited by this paper
• Health related quality of life for men treated for localized prostate cancer with long-term followup.

  2010cited by this paper
• Initial management of low‐risk localized prostate cancer in the UK: analysis of the British Association of Urological Surgeons Cancer Registry

  2010cited by this paper
• Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.

  2010cited by this paper
• Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up Study

  2010cited by this paper
• Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer.

  2010cited by this paper
• Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1)

  2010cited by this paper
• What would you do, doctor?

  2009cited by this paper
• Decision aids for people facing health treatment or screening decisions.

  2009cited by this paper
• Contemporary trends in low risk prostate cancer: risk assessment and treatment.

  2007cited by this paper
• The Efficacy and Safety of Multivitamin and Mineral Supplement Use To Prevent Cancer and Chronic Disease in Adults: A Systematic Review for a National Institutes of Health State-of-the-Science Conference

  2006cited by this paper
• Initial treatment patterns for clinically localized prostate cancer and factors associated with the treatment in Louisiana.

  2005cited by this paper
• Sociodemographic and clinical risk characteristics of patients with prostate cancer within the Veterans Affairs health care system: data from CaPSURE.

  2003cited by this paper
• Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.

  1994cited by this paper
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987cited by this paper

• Active Surveillance in Intermediate-Risk Prostate Cancer: A Contemporary Synthesis of Evidence.

  2025cites this paper
• External Validation of the International Staging Collaboration for Cancer of the Prostate (STAR-CAP) Prognostic System in Patients Managed with Active Surveillance

  2025cites this paper
• Key Determinants Influencing Treatment Decision-Making for and Adherence to Active Surveillance for Prostate Cancer: A Systematic Review

  2025cites this paper
• Influential Factors Impacting Treatment Decision-making and Decision Regret in Patients with Localized or Locally Advanced Prostate Cancer: A Systematic Literature Review.

  2024cites this paper
• Natural History of Nonmetastatic Prostate Cancer Managed With Watchful Waiting

  2024cites this paper
• Mesenchymal stem cell-derived exosomes for management of prostate cancer: An updated view.

  2024cites this paper
• Active surveillance should not be routinely considered in ISUP grade group 2 prostate cancer

  2023influential citation
• Prognostic Value of the Intermediate-risk Feature in Men with Favorable Intermediate-risk Prostate Cancer: Implications for Active Surveillance.

  2023cites this paper
• Comparison of Outcomes of Active Surveillance in Intermediate-Risk Versus Low-Risk Localised Prostate Cancer Patients: A Systematic Review and Meta-Analysis

  2023cites this paper
• Variations in the Uptake of Active Surveillance for Prostate Cancer and Its Impact on Outcomes

  2023cites this paper
• Active surveillance for low-risk prostate cancer: well established, yet avoided?

  2022cites this paper
• Evolving Trends in the Management of Low-Risk Prostate Cancer.

  2022cites this paper
• Satisfaction with Nurse-led Follow-up in Prostate Cancer Patients—A Nationwide Population-based Study

  2022cites this paper
• Five-year follow-up study of a population-based prospective cohort of men with low-risk prostate cancer: the treatment options in prostate cancer study (TOPCS): study protocol

  2022cites this paper
• Urinary marker panels for aggressive prostate cancer detection

  2022cites this paper
• Long-term Outcomes Among Men Undergoing Active Surveillance for Prostate Cancer in Sweden

  2022cites this paper
• Active surveillance for prostate cancer: selection criteria, guidelines, and outcomes

  2021cites this paper
• Comparing Active Surveillance and Watchful Waiting With Radical Treatment Using Machine Learning Models Among Patients With Prostate Cancer

  2021cites this paper
• Proteomic Analysis Identifies NDUFS1 and ATP5O as Novel Markers for Survival Outcome in Prostate Cancer

  2021cites this paper
• Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness.

  2021cites this paper
• High expression of SCHLAP1 in primary prostate cancer is an independent predictor of biochemical recurrence, despite substantial heterogeneity

  2021cites this paper
• Time Trends in Use of Radical Prostatectomy by Tumor Risk and Life Expectancy in a National Veterans Affairs Cohort

  2021cites this paper
• Active Surveillance—Is It Feasible for Intermediate-risk Localised Prostate Cancer?

  2021cites this paper
• Impact of a Genomic Test on Treatment Decision in a Predominantly African American Population With Favorable-Risk Prostate Cancer: A Randomized Trial

  2021cites this paper
• Risk-Based Selection for Active Surveillance: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Initiative

  2021cites this paper
• Prostate Cancer Research, 2000-16, its Citation Impact and its Influence on Clinical Practice Guidelines

  2020cites this paper
• Active Surveillance for Men with Intermediate Risk Prostate Cancer.

  2020cites this paper
• Prediction of pathologic upgrading in Gleason score 3+4 prostate cancer: Who is a candidate for active surveillance?

  2020cites this paper
• Differences in Use of Aggressive Therapy for Localized Prostate Cancer in New York City.

  2020cites this paper
• Temporal Changes in Demographic and Clinical Characteristics of Men With Prostate Cancer Electing for Conservative Management in the United States.

  2020cites this paper
• Patient-reported Health Status, Comorbidity Burden, and Prostate Cancer Treatment.

  2020cites this paper
• From the DEPARTMENT OF MEDICINE, SOLNA Karolinska Institutet, Stockholm, Sweden PROSTATE CANCER PROGNOSTICATION BASED ON CLINICAL AND HISTOPATHOLOGICAL TUMOR FEATURES

  2020cites this paper
• Selecting Active Surveillance: Decision Making Factors for Men with a Low-Risk Prostate Cancer

  2019cites this paper
• Active surveillance eligibility of MRI-positive patients with grade group 2 prostate cancer: a pathological study

  2019cites this paper
• The Treatments for Low-Risk Prostate Cancer

  2019cites this paper
• How to Pick Out the “Unreal” Gleason 3 + 3 Patients: A Nomogram for More Precise Active Surveillance Protocol in Low-Risk Prostate Cancer in a Chinese Population

  2019cites this paper
• Performance characteristics of prostate-specific antigen density and biopsy primary Gleason score to predict biochemical failure in patients with intermediate prostate cancer who underwent radical prostatectomy

  2019cites this paper
• Follow-up in Active Surveillance for Prostate Cancer: Strict Protocol Adherence Remains Important for PRIAS-ineligible Patients.

  2019cites this paper
• EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study).

  2019cites this paper
• Perceptions of Barriers Towards Active Surveillance for Low-Risk Prostate Cancer: Results From a National Survey of Radiation Oncologists and Urologists

  2018cites this paper
• Robotics in Genitourinary Surgery

  2018cites this paper
• National Trends in Active Surveillance for Prostate Cancer: Validation of Medicare Claims-based Algorithms.

  2018cites this paper
• Age at diagnosis and prognosis among prostate cancer patients treated with radiotherapy: evidenced from three independent cohort studies.

  2018cites this paper
• Decreased expression of serine protease inhibitor family G1 (SERPING1) in prostate cancer can help distinguish high-risk prostate cancer and predicts malignant progression.

  2018cites this paper
• Health Services Research and Robotic Surgery

  2018cites this paper
• Effects of Initial Gleason Grade on Outcomes during Active Surveillance for Prostate Cancer.

  2018cites this paper
• The Movember Foundation's GAP3 cohort: a profile of the largest global prostate cancer active surveillance database to date

  2018cites this paper
• Patient and provider experiences with active surveillance: A scoping review

  2018cites this paper
• Quality of care and economic considerations of active surveillance of men with prostate cancer

  2018cites this paper
• Baseline and longitudinal plasma caveolin‐1 level as a biomarker in active surveillance for early‐stage prostate cancer

  2018cites this paper
• Marges chirurgicales positives et progression biologique après prostatectomie totale pour tumeur de stade pT2

  2018influential citation
• Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort study

  2018cites this paper
• National trends in management of localized prostate cancer: A population based analysis 2004‐2013

  2018cites this paper
• Factors Influencing Men's Choice of and Adherence to Active Surveillance for Low-risk Prostate Cancer: A Mixed-method Systematic Review.

  2018influential citation
• Watchful waiting vs. active surveillance: Which treatment option is right for patients with localized prostate cancer?

  2018cites this paper
• Work-up and treatment of prostate cancer before and after publication of the first national guidelines on prostate cancer care in Sweden

  2018cites this paper
• Curative Radiation Therapy at Time of Progression Under Active Surveillance Compared With Up-front Radical Radiation Therapy for Prostate Cancer.

  2017cites this paper
• Variation in Guideline Concordant Active Surveillance Followup in Diverse Urology Practices

  2017cites this paper
• Impact of preoperative risk on metastatic progression and cancer‐specific mortality in patients with adverse pathology at radical prostatectomy

  2017cites this paper
• Qualitative study on decision‐making by prostate cancer physicians during active surveillance

  2017cites this paper
• Active surveillance for low-risk prostate cancer in Austria: the online registry of the Qualitätspartnerschaft Urologie (QuapU)

  2017cites this paper
• Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort Study.

  2017cites this paper
• Review of the comparative effectiveness of radical prostatectomy, radiation therapy, or expectant management of localized prostate cancer in registry data.

  2017cites this paper
• Active Surveillance in Younger Men With Prostate Cancer.

  2017influential citation
• Temporal Trends and the Impact of Race, Insurance, and Socioeconomic Status in the Management of Localized Prostate Cancer.

  2017cites this paper
• Re: Current Impact of Age and Comorbidity Assessment on Prostate Cancer Treatment Choice and Over/Undertreatment Risk.

  2017cites this paper
• Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling study

  2017cites this paper
• Analysis of active surveillance uptake for low-risk localized prostate cancer in Canada: a Canadian multi-institutional study

  2017cites this paper
• Current impact of age and comorbidity assessment on prostate cancer treatment choice and over/undertreatment risk

  2017cites this paper
• Creation and internal validation of a biopsy avoidance prediction tool to aid in the choice of diagnostic approach in patients with prostate cancer suspicion.

  2017cites this paper
• Regret and fear in prostate cancer: The relationship between treatment appraisals and fear of recurrence in prostate cancer survivors

  2017cites this paper
• Management of prostate cancer: NYU Case of the Month, July 2017.

  2017cites this paper
• The Emerging Role of MRI in Prostate Cancer Active Surveillance and Ongoing Challenges.

  2017cites this paper
• Re: Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden

  2017cites this paper
• Investigating engrailed-2 (EN2) as a therapeutic target in prostate cancer

  2017cites this paper
• Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden

  2017cites this paper
• Re: Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate Cancer.

  2017cites this paper
• Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform Decisions.

  2017cites this paper
• Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer.

  2017influential citation
• The Proteome of Primary Prostate Cancer.

  2016cites this paper
• Active Surveillance of Prostate Cancer: Use, Outcomes, Imaging, and Diagnostic Tools.

  2016cites this paper
• How Active is Active Surveillance? Intensity of Followup during Active Surveillance for Prostate Cancer in the United States.

  2016cites this paper
• Active surveillance for prostate cancer: current evidence and contemporary state of practice

  2016cites this paper
• The Association Between Evaluation at Academic Centers and the Likelihood of Expectant Management in Low-risk Prostate Cancer.

  2016cites this paper
• Re: Risk Group and Death from Prostate Cancer: Implications for Active Surveillance in Men with Favorable Intermediate-Risk Prostate Cancer.

  2016cites this paper
• Immediate versus delayed prostatectomy: Nationwide population-based study*

  2016cites this paper
• Active Surveillance for Intermediate Risk Prostate Cancer

  2016cites this paper
• Long-term Results of Active Surveillance in the Göteborg Randomized, Population-based Prostate Cancer Screening Trial.

  2016cites this paper
• Contemporary Management of Prostate Cancer Patients Suitable for Active Surveillance: A North American Population-based Study.

  2016cites this paper
• Active Surveillance of Prostate Cancer: Use, Outcomes, Imaging, and Diagnostic Tools.

  2016cites this paper
• The uptake of active surveillance for the management of prostate cancer: A population-based analysis.

  2016cites this paper
• Evaluation of the 2015 Gleason Grade Groups in a Nationwide Population-based Cohort.

  2016cites this paper
• Re: Expectant Management of Veterans with Early-Stage Prostate Cancer.

  2016cites this paper
• How Active is Active Surveillance ? Intensity of Follow-Up During Active Surveillance for Prostate Cancer in the United States Running Title : Intensity of Prostate Cancer Active Surveillance

  2016cites this paper
• A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the disease

  2016cites this paper
• Identification of candidates for observation

  2015cites this paper
• Active surveillance: protocol makes perfect.

  2015cites this paper
• A hospital-based study of initial observation for low-risk prostate cancer and its predictors in the United States.

  2015cites this paper
• [CLINICAL SURVEILLANCE OF PROSTATE CANCER--COMPARISON WITH CLINICAL MASS STUDY IN JAPAN].

  2015cites this paper
• Current use of active surveillance for localized prostate cancer: A nationwide survey in Japan

  2015cites this paper